QSAR and Drug Design: New Developments and Applications (eBook)
490 Seiten
Elsevier Science (Verlag)
978-0-08-054500-4 (ISBN)
They are categorized in three sections. Section one includes topics illustrating newer methodologies relating to ligand-receptor, molecular graphics and receptor modelling as well as the three-dimensional (Q)SAR examples with the active analogue approach and the comparative molecular field analysis. In section 2 the hydrophobicity parameters, log P (1-octanol/water) for compound series of medicinal-chemical interest are analysed physico-organic chemically. Section 3 contains the examples based on the traditional Hansch QSAR approach.
A variety of methodologies and procedures are presented in this single volume, along with their methodological philosophies.
Based on topics presented at the Annual Japanese (Quantitative) Structure-Activity Relationship Symposium and the Biennial China-Japan Drug Design and Development conference, the topics in this volume cover almost every procedure and subdiscipline in the SAR discipline.They are categorized in three sections. Section one includes topics illustrating newer methodologies relating to ligand-receptor, molecular graphics and receptor modelling as well as the three-dimensional (Q)SAR examples with the active analogue approach and the comparative molecular field analysis. In section 2 the hydrophobicity parameters, log P (1-octanol/water) for compound series of medicinal-chemical interest are analysed physico-organic chemically. Section 3 contains the examples based on the traditional Hansch QSAR approach.A variety of methodologies and procedures are presented in this single volume, along with their methodological philosophies.
Front Cover 1
QSAR and Drug Design: New Developments and Applications 4
Copyright Page 5
Contents 14
Preface 10
Section I: Three-Dimensional Structure-Based Drug Design, Molecular Modelling and Three-Dimensional QSAR 16
Chapter 1. Rational Approaches to Computer Drug Design Based on Drug-Receptor Interactions 18
Chapter 2. Drug Design Based on Receptor Modeling Using a System "BIOCES(E)" 64
Chapter 3. Mechanisms of the Selective Inhibition of Thrombin, Factor Xa, Plasmin and Trypsin 98
Chapter 4. Three-Dimensional Structure-Activity Relationships and Receptor Mapping of Quinolone Antibacterials 112
Chapter 5. Classical and Three-Dimensional Quantitative Structure-Activity Analyses of Steroid Hormones: Structure-Receptor Binding Patterns of Anti-hormonal Drug Candidates 140
Section II: Quantitative Structure-Parameter Analyses and Database-Oriented and Newer Statistical (Q)SAR Procedures and Drug Design 166
Chapter 6. Analysis and Prediction of 1-Octanol/Water Partition Coefficients of Substituted Diazines with Substituent and Structural Parameters 168
Chapter 7. Hydrophobicities of Di-to Pentapeptides Having Unionizable Side Chains and Correlation with Substituent and Structural Parameters 200
Chapter 8. Analysis of Amino Acid Sequence-Function Relationships in Proteins 230
Chapter 9. Background and Features of EMIL, A System for Database-Aided Bioanalogous Structural Transformation of Bioactive Compounds 250
Chapter 10. Fuzzy Adaptive Least Squares and its Use in Quantitative Structure- Activity Relationships 290
Sevtion III: Traditional QSAR and Drug Design. 312
Chapter 11. Structure-Activity Relationships in Medicinal Chemistry: Development of Drug Candidates from Lead Compounds 356
Chapter 12. Chemical Modification and Structure-Activity Relationship Studies of Piperine and its Analogs: An Example of Drug Development from Folk Medicine 336
Chapter 13. Structural Requirements of Leukotriene Antagonists 356
Chapter 14. Quantitative Structure-Activity Relationships of a New Class of Ca2+-Antagonistic and a –Blocking Phenoxyalkylamine Derivatives 384
Chapter 15. Applications of Quantitative Structure-Activity Relationships to Drug Design of Piperazine Derivatives 428
Chapter 16. Quantitative Structure-Activity Studies of Neurotoxic Acrylamide Analogs 466
Subject index 496
Erscheint lt. Verlag | 20.11.1995 |
---|---|
Sprache | englisch |
Themenwelt | Mathematik / Informatik ► Informatik ► Theorie / Studium |
Medizin / Pharmazie ► Gesundheitsfachberufe | |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie | |
Medizin / Pharmazie ► Pharmazie | |
Naturwissenschaften ► Chemie ► Organische Chemie | |
Technik ► Maschinenbau | |
Wirtschaft | |
ISBN-10 | 0-08-054500-9 / 0080545009 |
ISBN-13 | 978-0-08-054500-4 / 9780080545004 |
Haben Sie eine Frage zum Produkt? |
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich